INVESTING IN THE DEVELOPMENT OF NEW ANTIBIOTICS AND THEIR CONSERVATION:
A PROPOSAL FOR A GLOBAL ANTIBIOTIC RESEARCH AND DEVELOPMENT FACILITY
TECHNICAL CONSULTATION JOINTLY HOSTED BY THE
WORLD HEALTH ORGANIZATION AND THE DRUGS FOR NEGLECTED DISEASES INITIATIVE
13 NOVEMBER 2015
LIST OF PARTICIPANTS
Andreas Aeschlimann, Joint Programming AMR, Switzerland
Mirza Alas, South Centre, Switzerland
Maged Al-Sherbiny, Ministry of Higher Education and Scientific Research, Egypt
James Anderson, GSK, UK
Christine Ardal, Norwegian Institute of Public Health, Norway
Elvire Aronica, Délégation aux Affaires Européennes et Internationales, France
Hala Audi, Review on Antimicrobial Resistance, UK
Manica Balasegaram, MSF Access Campaign, Switzerland
Emmanuel Baron, Epicentre, France
Martin Barth, Federal Ministry of Research, Germany
Richard Bergström, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Arnaud Bernaert, World Economic Forum, Switzerland
Esther Bettiol, Hôpitaux Universitaires de Genève, Switzerland
Catharina Boehme, FIND, Switzerland
Esteban Burrone, Medecines Patent Pool, Switzerland
Otto Cars, Uppsala University/ReAct, Sweden
Anthony Coates, St George's, University of London, UK
Marion Courbil, Mission permanente de la France auprès des Nations Unies à Genève et des
Organisations Internationales en Suisse, France
Guilherme de Aguiar Patriota, Permanent Mission of Brazil to the United Nations in Geneva, Brazil
Tania Dussey-Cavassini, Office Federal de la Santé Publique, Switzerland
Sandra Dybowski, Ministry of Health, Germany
Marit Elenbaas, Ministry of Health, Welfare and Sport, The Netherlands
Marja Esveld, Ministry of Health, Welfare and Sport, The Netherlands
Laurent Fraisse, Sanofi, France
Rosalia Framil, Permanent Mission of Chile to the United Nations in Geneva, Chile
Nirmal Ganguly, National Institute of Immunology, India
Charlie Garnjana-Goonchorn, Permanent Mission of Thailand the United Nations in Geneva, Thailand
Hellen Gelband, Center for Disease Dynamics, Economics & Policy, USA
Dylan George, Office of Science and Technology Policy, US Government, USA
Richard Gordon, Medical Research Council, South Africa
Nina Grundmann, International Federation of Pharmaceutical Manufacturers, Switzerland
Anna Halén, Permanent Mission of Sweden to the United Nations in Geneva, Sweden
Raga Naseem Hammad, Permanent Mission of the State of Qatar to the United Nations in Geneva, Qatar
Stephan Harbarth, Hôpitaux Universitaires de Genève, Switzerland
Nadia Khelef, Institut Pasteur, France
Sue Kinn, Department for International Development, UK
Jeremy Knox, Review on Antimicrobial Resistance, UK
Joseph Larsen, Broad Spectrum Antimicrobials Program at the Biomedical Advanced Research
Development Authority (BARDA), Department of Health & Human Services, USA
Thor Erik Lindgren, Norway, Permanent Mission to the UN in Geneva, Norway
Emmanuel Makasa, Permanent Mission of the Republic of Zambia to the United Nations in Geneva,
Zambia
Laura Marin, JPIAMR - Swedish Research Council, Sweden
Precious Malebona Matsoso, South African National Department of Health, South Africa
Maya Matthews, Permanent Delegation of the European Union to the United Nations Office and other
international organizations, Geneva, European Union
Colin Mc lff, Permanent Mission of the United States of America to the United Nations in Geneeva, USA
Grissel Mnisi, Directorate: South-South Relations, National Department of Health, South Africa
Viviana Munoz, South Centre, Switzerland
Hideaki Nishizawa, Ministry of Foreign Affairs, Japan
Eisah A. Rahman, Ministry of Health, Malaysia
E. Vishnu Vardhan Reddy, Permanent Mission of India to the United Nations Office in Geneva, India
Dagmar Reitenbach, Ministry of Health, Germany
Hilary Robinson, Health Security Infrastructure Branch, Public Health Agency of Canada, Canada
John-Arne Røttingen, Norwegian Institute of Public Health, Norway
Paul Schaper, MSD, USA
Lucas Vinicius Sversut, Permanent Mission of Brazil to the United Nations in Geneva, Brazil
Arjon Van Hengel, European Commission, Directorate-General for Research and Innovation, Unit of
Infectious diseases and Public Health, European Union
Alexandre von Kessel, Office Fédéral de la Santé Publique, Switzerland
Yonghong Xiao, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,
State Key Laboratory for Diagnosis and Treatment of Infectious Disease, First Affiliated Hospital, College
of Medicine, Zhejiang University, China
DNDi Participants:
Jean-François Alesandrini, DNDi, Switzerland
Graeme Bilbe, DNDi, Switzerland
Michelle Childs, DNDi, Brazil
Gabrielle Landry Chappuis, DNDi, Switzerland
Jean-Pierre Paccaud, DNDi, Switzerland
Bernard Pécoul, DNDi, Switzerland
Nathalie Strub-Wourgaft, DNDi, Switzerland
WHO Participants:
Taghreed Adam, WHO, Switzerland
Peter Beyer, WHO, Switzerland
Kees de Joncheere, WHO, Switzerland
Marie-Paule Kieny, WHO, Switzerland
Zafar Mirza, WHO, Switzerland
Marcus Sprenger, WHO, Switzerland
Elizabeth Tayler, WHO, Switzerland